Bio Green Med Solution, Inc. Common Stock (BGMS) Stock Price

BGMSStock

$0.91−76.13%52W

Market Cap$6.02M

P/E—

PEG Ratio—

Div yield—

Beta-0.40

BGMS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-22.47%

Price vs S&P 500 (4W)-2.79%

VGM Score57.59

Book Value / Share (Quarterly)$1.08

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.17

Price vs S&P 500 (YTD)-50.49%

Gross Margin (TTM)19.34%

Net Profit Margin (TTM)-118.27%

EPS (TTM)$-0.76

10-Day Avg Trading Volume0.05M

EPS Excl Extra (TTM)$-0.76

EPS (Annual)$-1.37

Dividend / Share (Annual)$0.02

ROI (Annual)-43.82%

Gross Margin (Annual)18.47%

Net Profit Margin (5Y Avg)-7621.91%

Cash / Share (Quarterly)$0.57

Revenue Growth QoQ (YoY)710.00%

ROA (Last FY)-36.63%

Revenue Growth TTM (YoY)18510.00%

EBITD / Share (TTM)$-0.62

ROE (5Y Avg)-788.35%

Operating Margin (TTM)-147.13%

Cash Flow / Share (Annual)$-0.88

P/B Ratio0.84x

P/B Ratio (Quarterly)0.84x

EV / Revenue (TTM)1.20x

Net Interest Coverage (TTM)-284.57x

ROA (TTM)-27.72%

EPS Incl Extra (Annual)$-1.37

Current Ratio (Annual)4.70x

Quick Ratio (Quarterly)7.17x

3-Month Avg Trading Volume0.11M

52-Week Price Return-76.13%

P/S Ratio (Annual)8.06x

Asset Turnover (Annual)0.09x

52-Week High$5.79

Operating Margin (5Y Avg)-8498.71%

EPS Excl Extra (Annual)$-1.37

26-Week Price Return-12.57%

Quick Ratio (Annual)3.66x

13-Week Price Return-4.07%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)8.63x

Enterprise Value$2.23M

Asset Turnover (TTM)0.23x

Inventory Turnover (Annual)1.67x

Pretax Margin (Annual)-400.40%

Cash / Share (Annual)$0.65

3-Month Return Std Dev79.07%

Gross Margin (5Y Avg)62.05%

ROE (Last FY)-43.82%

Net Interest Coverage (Annual)-97.86x

EPS Basic Excl Extra (Annual)$-1.37

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.76

ROI (TTM)-31.60%

Dividend Growth Rate (5Y)-39.23%

P/S Ratio (TTM)3.24x

Pretax Margin (5Y Avg)-8353.92%

Revenue / Share (Annual)$0.34

Price vs S&P 500 (52W)-91.67%

Year-to-Date Return-38.56%

5-Day Price Return-8.15%

EPS Normalized (Annual)$-1.37

ROA (5Y Avg)-137.62%

Net Profit Margin (Annual)-401.34%

Month-to-Date Return3.08%

EBITD / Share (Annual)$-1.59

Operating Margin (Annual)-465.86%

ROI (5Y Avg)-788.35%

EPS Basic Excl Extra (TTM)$-0.76

P/B Ratio (Annual)1.06x

Dividend / Share (TTM)$0.01

Inventory Turnover (TTM)3.39x

Pretax Margin (TTM)-115.91%

Book Value / Share (Annual)$1.27

Price vs S&P 500 (13W)-6.76%

Dividend Yield (TTM)1.01%

Beta-0.40x

Revenue / Share (TTM)$0.33

ROE (TTM)-31.60%

52-Week Low$0.57

vGradeD

gGradeA

mGradeD

vgmGradeC

BGMS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q3 2024	Nov 12, 2024	-$129.60	-$43.20	+66.67%(+$86.40)
Q2 2024	Aug 14, 2024	-$344.40	-$172.80	+49.83%(+$171.60)
Q1 2024	May 14, 2024	-$1183.20	-$544.80	+53.96%(+$638.40)
Q4 2023	Mar 19, 2024	-$1524.00	-$1495.20	+1.89%(+$28.80)

BGMS Analyst Recommendations

Nov 2024

Dec 2024

Jan 2025

Feb 2025

4.13

2.17

Industry Peers — Wholesale — Durable Goods(4)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	ROE (TTM)	Operating Margin (TTM)	Revenue Growth TTM (YoY)	Price
BGMSBio Green Med Solution, Inc. Common Stock	D	A	D	—	-31.6%	-147.1%	18510.0%	$0.91
CNMCore & Main, Inc.	C	B	C	18.1x	22.8%	9.6%	-0.5%	$41.99
AENTAlliance Entertainment Holding Corporation Class A Common Stock	B	D	D	17.6x	11.3%	2.3%	8.0%	$4.50
GNLNGreenlane Holdings, Inc. Class A Common Stock	A	F	F	—	-314.9%	-1985.3%	-63.1%	$2.06
AENTWAlliance Entertainment Holding Corporation Warrants	—	—	F	—	—	—	—	$0.15

About Bio Green Med Solution, Inc. Common Stock

Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company developing targeted cancer therapies through CDK and PLK inhibitor programs, including lead candidates fadraciclib and plogosertib. The company addresses proliferative diseases by targeting cell cycle pathways and operates from the United Kingdom.